REGENXBIO to Participate in Upcoming Investor Conferences

ROCKVILLE, Md., Oct. 15, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines Conference Panel "Battleground States for Muscular Dystrophies": Tuesday, October 21 at 2:00 p.m....